HYRIMOZ
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
61314-476 -
Package NDC
61314-476-64 -
Application number
BLA761071 -
SPL ID
48b7e44a-945f-487d-b2fd-3da13d6d6fdb -
SPL set ID
1ac7d061-3380-468c-b077-c05f8dfbc829 -
UNII
FYS6T7F842 -
RxCUI
2641644 -
RxCUI
2641650 -
RxCUI
2641653 -
RxCUI
2641654 -
RxCUI
2641655 -
RxCUI
2641658 -
RxCUI
2641660 -
RxCUI
2641661 -
RxCUI
2641662 -
RxCUI
2641663 -
RxCUI
2641664 -
RxCUI
2641665 -
RxCUI
2641666 -
RxCUI
2641667 -
RxCUI
2641668 -
RxCUI
2641669 -
RxCUI
2641670 -
RxCUI
2641671 -
RxCUI
2641672 -
RxCUI
2641673
What the source publishes
- Labeler
- Sandoz Inc
- Active ingredients
- adalimumab-adaz
- Form
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "HYRIMOZ",
"splId": "48b7e44a-945f-487d-b2fd-3da13d6d6fdb",
"labels": [
{
"setId": "1ac7d061-3380-468c-b077-c05f8dfbc829",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1ac7d061-3380-468c-b077-c05f8dfbc829",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1ac7d061-3380-468c-b077-c05f8dfbc829"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Sandoz Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "2 SYRINGE, GLASS in 1 CARTON (61314-476-64) / .2 mL in 1 SYRINGE, GLASS",
"package_ndc": "61314-476-64",
"identifierStatus": "well-formed",
"marketing_start_date": "20230701"
}
],
"productId": "61314-476_48b7e44a-945f-487d-b2fd-3da13d6d6fdb",
"useDomain": "unknown",
"dosageForm": "INJECTION, SOLUTION",
"productNdc": "61314-476",
"deaSchedule": null,
"genericName": "adalimumab-adaz",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ADALIMUMAB",
"strength": "20 mg/.2mL"
}
],
"applicationNumber": "BLA761071",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230701",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175610",
"N0000175451",
"M0001357"
],
"unii": [
"FYS6T7F842"
],
"rxcui": [
"2641644",
"2641650",
"2641653",
"2641654",
"2641655",
"2641658",
"2641660",
"2641661",
"2641662",
"2641663",
"2641664",
"2641665",
"2641666",
"2641667",
"2641668",
"2641669",
"2641670",
"2641671",
"2641672",
"2641673"
],
"spl_set_id": [
"1ac7d061-3380-468c-b077-c05f8dfbc829"
],
"pharm_class_cs": [
"Antibodies, Monoclonal [CS]"
],
"pharm_class_epc": [
"Tumor Necrosis Factor Blocker [EPC]"
],
"pharm_class_moa": [
"Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
],
"manufacturer_name": [
"Sandoz Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:61314-476_48b7e44a-945f-487d-b2fd-3da13d6d6fdb"